Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Nature Communications|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Communications Biology|January 19, 2022
Rare germline copy number variants (CNVs) and breast cancer riskJoe Dennis, Jonathan P Tyrer, Logan C Walker, et al.
Breast Cancer Research : BCR|December 29, 2024
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk predictionKristia Yiangou, Nasim Mavaddat, Joe Dennis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2024
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk predictionKristia Yiangou, Nasim Mavaddat, Joe Dennis, et al.
Human Mutation|May 10, 2024
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to BRCA1 and BRCA2Maria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Breast Cancer Research : BCR|August 9, 2023
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestryPooja Middha, Xiaoliang Wang, Sabine Behrens, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2021
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association ConsortiumAnna Morra, Audrey Y Jung, Sabine Behrens, et al.
Breast Cancer Research : BCR|August 19, 2021
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatmentAnna Morra, Maria Escala-Garcia, Jonathan Beesley, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Pageof 20